Three months of CGRP mAb therapy for chronic migraine showed no significant overall change in plasma cytokine expression, supporting the safety profile.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback